Editorial
IgA nephropathy: What patients are at risk of progression to end-stage renal disease and how should they be treated?
Nefropatía IgA: ¿qué pacientes están en riesgo de progresar a enfermedad renal terminal y cómo deberían ser tratados?
Manuel Pragaa,b,
, Fernando Caravacaa, Claudia Yustea, Teresa Caveroa, Eduardo Hernándeza, Enrique Moralesa, Eva Méridaa, Juan Antonio Morenoc, Angel Sevillanoa, Eduardo Gutiérreza
Corresponding author
a Servicio de Nefrología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria, Hospital 12 de Octubre (imas12), Madrid, Spain
b Departamento de Medicina, Universidad Complutense, Madrid, Spain
c Renal, Vascular and Diabetes Research Laboratory, Fundación Instituto de Investigaciones Sanitarias-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain
Read
3485
Timeswas read the article
490
Total PDF
2844
Total HTML
151
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2019 July | 356 | 41 | 12 | 409 |
| 2019 June | 469 | 70 | 11 | 550 |
| 2019 May | 390 | 85 | 16 | 491 |
| 2019 April | 394 | 77 | 10 | 481 |
| 2019 March | 199 | 56 | 6 | 261 |
| 2019 February | 129 | 21 | 3 | 153 |
| 2019 January | 141 | 33 | 8 | 182 |
| 2018 December | 118 | 35 | 25 | 178 |
| 2018 November | 260 | 19 | 16 | 295 |
| 2018 October | 179 | 12 | 8 | 199 |
| 2018 September | 81 | 13 | 12 | 106 |
| 2018 August | 58 | 10 | 10 | 78 |
| 2018 July | 53 | 16 | 12 | 81 |
| 2018 June | 17 | 2 | 2 | 21 |
Show all
